ID EPOR_RAT Reviewed; 507 AA. AC Q07303; DT 01-FEB-1995, integrated into UniProtKB/Swiss-Prot. DT 01-FEB-1995, sequence version 1. DT 24-JAN-2024, entry version 157. DE RecName: Full=Erythropoietin receptor; DE Short=EPO-R; DE Flags: Precursor; GN Name=Epor; OS Rattus norvegicus (Rat). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Rattus. OX NCBI_TaxID=10116; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM EPOR-F). RC TISSUE=Pheochromocytoma; RX PubMed=7684373; DOI=10.1016/s0021-9258(18)82112-3; RA Masuda S., Nagao M., Takahata K., Konishi Y., Gallyas F., Tabira T., RA Sasaki R.; RT "Functional erythropoietin receptor of the cells with neural RT characteristics. Comparison with receptor properties of erythroid cells."; RL J. Biol. Chem. 268:11208-11216(1993). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS EPOR-F AND EPOR-S). RC STRAIN=Long Evans; RX PubMed=9029168; DOI=10.1016/s0304-3835(96)04544-2; RA Fujita M., Takahashi R., Kitada K., Watanabe R., Kitazawa S., Ashoori F., RA Liang P., Saya H., Serikawa T., Maeda S.; RT "Alternative splicing of the erythropoietin receptor gene correlates with RT erythroid differentiation in rat hematopoietic and leukemic cells."; RL Cancer Lett. 112:47-55(1997). CC -!- FUNCTION: Receptor for erythropoietin. Mediates erythropoietin-induced CC erythroblast proliferation and differentiation. Upon EPO stimulation, CC EPOR dimerizes triggering the JAK2/STAT5 signaling cascade. In some CC cell types, can also activate STAT1 and STAT3. May also activate LYN CC tyrosine kinase (By similarity). {ECO:0000250}. CC -!- SUBUNIT: Forms homodimers on EPO stimulation. The tyrosine- CC phosphorylated form interacts with several SH2 domain-containing CC proteins including LYN, the adapter protein APS, PTPN6, PTPN11, JAK2, CC PI3 kinases, STAT5A/B, SOCS3 and CRKL. The N-terminal SH2 domain of CC PTPN6 binds Tyr-453 and inhibits signaling through dephosphorylation of CC JAK2. APS binding also inhibits the JAK-STAT signaling. Binding to CC PTPN11, preferentially through the N-terminal SH2 domain, promotes CC mitogenesis and phosphorylation of PTPN11. Binding of JAK2 (through its CC N-terminal) promotes cell-surface expression. Interaction with the CC ubiquitin ligase NOSIP mediates EPO-induced cell proliferation. CC Interacts with ATXN2L and INPP5D/SHIP1 (By similarity). {ECO:0000250}. CC -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=EPOR-F; Synonyms=Full-length form; CC IsoId=Q07303-1; Sequence=Displayed; CC Name=EPOR-S; Synonyms=Soluble form; CC IsoId=Q07303-2; Sequence=VSP_009514, VSP_009515; CC -!- TISSUE SPECIFICITY: Isoform EPOR-F and isoform EPOR-S are expressed in CC bone marrow, spleen and eythroleukemia cell lines. CC -!- DOMAIN: The WSXWS motif appears to be necessary for proper protein CC folding and thereby efficient intracellular transport and cell-surface CC receptor binding. CC -!- DOMAIN: The box 1 motif is required for JAK interaction and/or CC activation. CC -!- DOMAIN: Contains 1 copy of a cytoplasmic motif that is referred to as CC the immunoreceptor tyrosine-based inhibitor motif (ITIM). This motif is CC involved in modulation of cellular responses. The phosphorylated ITIM CC motif can bind the SH2 domain of several SH2-containing phosphatases. CC -!- PTM: On EPO stimulation, phosphorylated on C-terminal tyrosine residues CC by JAK2. The phosphotyrosine motifs are also recruitment sites for CC several SH2-containing proteins and adapter proteins which mediate cell CC proliferation. Phosphorylation on Tyr-453 is required for PTPN6 CC interaction, Tyr-425 for PTPN11. Tyr-425 is also required for SOCS3 CC binding, but Tyr-453/Tyr-455 motif is the preferred binding site (By CC similarity). {ECO:0000250}. CC -!- PTM: Ubiquitinated by NOSIP; appears to be either multi- CC monoubiquitinated or polyubiquitinated. Ubiquitination mediates CC proliferation and survival of EPO-dependent cells. Ubiquitination at CC Lys-280 mediates receptor internalization, whereas ubiquitination at CC Lys-452 promotes trafficking of activated receptors to the lysosomes CC for degradation (By similarity). {ECO:0000250}. CC -!- SIMILARITY: Belongs to the type I cytokine receptor family. Type 1 CC subfamily. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; D13566; BAA02761.1; -; mRNA. DR PIR; A46713; A46713. DR AlphaFoldDB; Q07303; -. DR SMR; Q07303; -. DR STRING; 10116.ENSRNOP00000017369; -. DR GlyCosmos; Q07303; 1 site, No reported glycans. DR GlyGen; Q07303; 1 site. DR iPTMnet; Q07303; -. DR PhosphoSitePlus; Q07303; -. DR PaxDb; 10116-ENSRNOP00000017369; -. DR Ensembl; ENSRNOT00055021579; ENSRNOP00055017493; ENSRNOG00055012644. [Q07303-1] DR Ensembl; ENSRNOT00060050635; ENSRNOP00060042129; ENSRNOG00060029173. [Q07303-1] DR UCSC; RGD:2560; rat. [Q07303-1] DR AGR; RGD:2560; -. DR RGD; 2560; Epor. DR eggNOG; ENOG502RYHW; Eukaryota. DR InParanoid; Q07303; -. DR PhylomeDB; Q07303; -. DR Reactome; R-RNO-9006335; Signaling by Erythropoietin. DR Reactome; R-RNO-9027276; Erythropoietin activates Phosphoinositide-3-kinase (PI3K). DR Reactome; R-RNO-9027284; Erythropoietin activates RAS. DR PRO; PR:Q07303; -. DR Proteomes; UP000002494; Unplaced. DR GO; GO:0009986; C:cell surface; IDA:RGD. DR GO; GO:0009897; C:external side of plasma membrane; IDA:RGD. DR GO; GO:0004900; F:erythropoietin receptor activity; IDA:RGD. DR GO; GO:0042802; F:identical protein binding; ISO:RGD. DR GO; GO:0007420; P:brain development; ISO:RGD. DR GO; GO:1904374; P:cellular response to kainic acid; IEP:RGD. DR GO; GO:0019221; P:cytokine-mediated signaling pathway; IBA:GO_Central. DR GO; GO:0046697; P:decidualization; ISO:RGD. DR GO; GO:0007507; P:heart development; ISO:RGD. DR GO; GO:0030097; P:hemopoiesis; IBA:GO_Central. DR GO; GO:0043524; P:negative regulation of neuron apoptotic process; IMP:RGD. DR GO; GO:0045019; P:negative regulation of nitric oxide biosynthetic process; IMP:RGD. DR GO; GO:0008284; P:positive regulation of cell population proliferation; IMP:RGD. DR GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IDA:RGD. DR GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IMP:RGD. DR GO; GO:0010976; P:positive regulation of neuron projection development; IMP:RGD. DR GO; GO:1901033; P:positive regulation of response to reactive oxygen species; IMP:RGD. DR GO; GO:0001666; P:response to hypoxia; IEP:RGD. DR GO; GO:0007165; P:signal transduction; ISO:RGD. DR CDD; cd00063; FN3; 1. DR Gene3D; 2.60.40.10; Immunoglobulins; 2. DR InterPro; IPR009167; Erythropoietin_rcpt. DR InterPro; IPR003961; FN3_dom. DR InterPro; IPR036116; FN3_sf. DR InterPro; IPR015152; Growth/epo_recpt_lig-bind. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR003528; Long_hematopoietin_rcpt_CS. DR PANTHER; PTHR23037; CYTOKINE RECEPTOR; 1. DR PANTHER; PTHR23037:SF28; ERYTHROPOIETIN RECEPTOR; 1. DR Pfam; PF09067; EpoR_lig-bind; 1. DR Pfam; PF00041; fn3; 1. DR PIRSF; PIRSF001959; EPO_receptor; 1. DR SMART; SM00060; FN3; 1. DR SUPFAM; SSF49265; Fibronectin type III; 2. DR PROSITE; PS50853; FN3; 1. DR PROSITE; PS01352; HEMATOPO_REC_L_F1; 1. PE 2: Evidence at transcript level; KW Alternative splicing; Disulfide bond; Glycoprotein; Isopeptide bond; KW Membrane; Phosphoprotein; Receptor; Reference proteome; Signal; KW Transmembrane; Transmembrane helix; Ubl conjugation. FT SIGNAL 1..24 FT /evidence="ECO:0000250" FT CHAIN 25..507 FT /note="Erythropoietin receptor" FT /id="PRO_0000010871" FT TOPO_DOM 25..249 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 250..272 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 273..507 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT DOMAIN 146..246 FT /note="Fibronectin type-III" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00316" FT REGION 384..423 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 466..507 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOTIF 232..236 FT /note="WSXWS motif" FT MOTIF 281..289 FT /note="Box 1 motif" FT MOTIF 451..456 FT /note="ITIM motif" FT COMPBIAS 396..423 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT SITE 116 FT /note="Required for ligand binding" FT /evidence="ECO:0000250" FT SITE 367 FT /note="Interaction with APS and STAT5, and activation" FT SITE 425 FT /note="Required for STAT5/PTPN11/SOCS3 binding" FT SITE 453 FT /note="Interaction with PTPN6" FT MOD_RES 367 FT /note="Phosphotyrosine; by JAK2" FT /evidence="ECO:0000250|UniProtKB:P14753" FT MOD_RES 425 FT /note="Phosphotyrosine; by JAK2" FT /evidence="ECO:0000250|UniProtKB:P14753" FT MOD_RES 453 FT /note="Phosphotyrosine; by JAK2" FT /evidence="ECO:0000250|UniProtKB:P14753" FT MOD_RES 455 FT /note="Phosphotyrosine; by JAK2" FT /evidence="ECO:0000250|UniProtKB:P14753" FT MOD_RES 467 FT /note="Phosphotyrosine; by JAK2" FT /evidence="ECO:0000250|UniProtKB:P14753" FT MOD_RES 484 FT /note="Phosphotyrosine; by JAK2" FT /evidence="ECO:0000250|UniProtKB:P14753" FT MOD_RES 488 FT /note="Phosphotyrosine; by JAK2" FT /evidence="ECO:0000250|UniProtKB:P14753" FT MOD_RES 503 FT /note="Phosphotyrosine; by JAK2" FT /evidence="ECO:0000250|UniProtKB:P14753" FT CARBOHYD 75 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT DISULFID 52..62 FT /evidence="ECO:0000250" FT DISULFID 90..106 FT /evidence="ECO:0000250" FT CROSSLNK 280 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in ubiquitin)" FT /evidence="ECO:0000250|UniProtKB:P14753" FT CROSSLNK 452 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in ubiquitin)" FT /evidence="ECO:0000250|UniProtKB:P14753" FT VAR_SEQ 246..265 FT /note="DLDPLILTLSLILVLISLLL -> GEATVPRGGGGAGPNTSKPP (in FT isoform EPOR-S)" FT /evidence="ECO:0000303|PubMed:9029168" FT /id="VSP_009514" FT VAR_SEQ 266..507 FT /note="Missing (in isoform EPOR-S)" FT /evidence="ECO:0000303|PubMed:9029168" FT /id="VSP_009515" SQ SEQUENCE 507 AA; 55500 MW; AC79AF22D06A7312 CRC64; MDQLRVARWP RVSPLCLLLA GAAWASSPSL PDPKFESKAA LLASRGSEEL LCFTQRLEDL VCFWEEAANS GMGFNYSFSY QLEGESRKSC RLHQAPTVRG SMRFWCSLPT ADTSSFVPLE LQVTEASGSP RYHRIIHINE VVLLDAPAGL LARRAEEGSH VVLRWLPPPG APMTTHIRYE VDVSAGNRAG GTQRVEVLEG RTECVLSNLR GGTRYTFAVR ARMAEPSFSG FWSAWSEPAS LLTASDLDPL ILTLSLILVL ISLLLTVLAL LSHRRALRQK IWPGIPSPEN EFEGLFTTHK GNFQLWLLQR DGCLWWSPSS PFPEDPPAHL EVLSERRWGV TQAGDAGAED KGPLLEPVGS ERAQDTYLVL DEWLLPRCPC SENLSGPGDS VDPATMDEGS ETSSCPSDLA SKPRPEGTSP SSFEYTILDP SSKLLCPRAL PPELPPTPPH LKYLYLVVSD SGISTDYSSG GSQGVHGDSS DGPYSHPYEN SLVPDTEPLR PSYVACS //